Health
NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells – News-Medical.Net
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and…
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
The findings were published today in Clinical Cancer Research, a journal of the American Association for Cancer Research. These results led to…
-
Noosa News17 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News18 hours agoMotorcyclist dies in crash with truck
-
Noosa News19 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General24 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging